市場調查報告書
商品編碼
1454021
到 2030 年生命徵象監測系統市場預測:按產品類型、消費性穿戴裝置、技術、應用、最終用戶和地區進行的全球分析Vital Signs Monitoring Systems Market Forecasts to 2030 - Global Analysis By Product Type, Type, Consumer Wearables, Technology, Application, End User and By Geography |
根據 Stratistics MRC 的數據,2023 年全球生命徵象監測系統市場規模為 101 億美元,預計在預測期內將以 10.5% 的年複合成長率成長,到 2030 年達到 204 億美元。
生命徵象監測系統是先進的醫療設備,旨在追蹤重要的生理參數並及時檢測健康異常。這些系統持續監測心率、血壓、呼吸頻率和體溫等指標。利用尖端的感測器技術並提供即時資料,醫療保健專業人員可以快速回應患者病情的變化。這些系統可攜式且方便用戶使用,透過促進遠端監控和早期療育改善患者照護。
根據全球健康觀察站的資料,2019年,71%的死亡是由於非傳染性疾病(NCD)造成的。主要的非傳染性疾病是心血管疾病(CVD),佔所有非傳染性疾病死亡的 45.0%;癌症,佔所有非傳染性疾病死亡的 22.0%;以及慢性阻塞性肺病(COPD),佔所有非傳染性疾病死亡的10.0%。
慢性病增加
隨著高血壓、糖尿病和心血管疾病等疾病變得越來越普遍,持續健康監測的需求也隨之增加。生命徵象監測系統透過提供關鍵參數的即時資料並支援慢性病的早期檢測和管理發揮著至關重要的作用。該市場對方便用戶使用的遠端監控解決方案的需求激增,推動了創新。隨著人們對預防性醫療保健的日益關注,市場正在不斷擴大,以滿足患者和醫療保健提供者不斷成長的需求,從而促進了全面健康監測系統的動態發展。
初始成本和持續成本高
醫療保健組織可能會猶豫是否要投資此類系統,尤其是在資源有限的環境中。經濟負擔限制了普及並阻礙了提供者和患者的可及性。這一障礙減緩了先進監測技術融入主流醫療保健的速度,並抑制了持續遠端患者監護的潛在優勢。
家庭醫療保健需求不斷成長
隨著人們尋求更方便和個人化的醫療保健解決方案,對在家監測生命徵象的偏好正在增加。生命徵象監測系統透過提供使用者友善的行動裝置來滿足此需求,這些設備可實現持續的健康追蹤。該市場正在見證穿戴式監控設備和遠端醫療整合等創新的激增,促進遠距患者照護。人口老化和 COVID-19 大流行等因素加速了向家庭醫療保健的轉變,正在推動市場擴張,以滿足患者對主動且易於使用的健康監測解決方案不斷變化的需求。
越來越依賴數位平台進行資料存儲
網路安全威脅是一個重大風險,可能使敏感的病患資訊面臨風險。這導致醫療保健提供者和患者的抵制增加,阻礙了普及。對未授權存取和資料外洩的擔憂可能會阻礙將先進監控技術引入醫療環境。因此,解決和緩解這些安全挑戰對於建立對數位醫療解決方案的信任、確保患者資料的安全和合乎道德的使用以及促進永續的市場成長至關重要。
COVID-19 的影響
隨著人們對遠端患者監護和遠端醫療的日益關注,醫療保健提供者擴大利用這些系統來遠端監測 COVID-19 患者。為了最大限度地減少病毒傳播,對非接觸式生命徵象監測解決方案的需求正在迅速增加。此外,這場流行病凸顯了早期發現和持續監測的重要性,刺激了對先進技術的投資。為了應對不斷變化的醫療保健環境,市場正在見證技術創新和協作的興起,在當前的全球健康危機期間,生命徵象監測可以加強患者照護並支持醫療保健專業人員,該系統的作用得到了強調。
血壓計細分市場預計將成為預測期內最大的細分市場
由於高血壓和心血管疾病的盛行率不斷上升,將推動對家庭血壓監測設備的需求以及綜合生命徵象監測系統的同步成長,血壓監測儀領域預計將出現良好的成長。將血壓監測先進地整合到這些系統中增強了診斷能力並吸引了醫療保健專業人員和消費者。此外,隨著技術的發展,技術創新和市場競爭的加劇提供了更準確和方便用戶使用的解決方案。
預測期內,門診血壓計領域預估年複合成長率最高
預計動態血壓計領域在預測期內將以最高年複合成長率成長。這是由於對連續和遠端病患監測的需求,動態血壓計在提供臨床環境之外的即時資料方面發揮著至關重要的作用。與綜合監測系統的整合擴大了市場範圍,並允許進行更全面的健康評估。動態監視器有助於動態的市場格局,響應醫療保健專業人員和患者不斷變化的偏好,尋求方便和持續的生命徵象追蹤,最終推動更廣泛的監護系統市場的創新和競爭。
預計亞太地區在預測期內將佔據最大的市場佔有率。其主要原因是老年人口不斷成長、持續性疾病數量不斷增加、人們對遠端和無線設備的興趣開拓以及保險覆蓋政策的簡化。這是由於該地區廣泛的未滿足需求,包括初級醫療保健,特別是在印度和中國等新興市場。此外,在預測期內,該地區醫療旅遊業的興起和醫療保健行業的改善也為市場參與者提供了許多幫助。
由於人口眾多、可支配收入高、患者對先進監測設備的認知不斷提高,以及瘧疾和傷寒等感染疾病率上升,北美將成為預測期內成長最快的地區,預計年複合成長率將很高。此外,老年人口的增加和家庭照護環境中對生命徵象監測系統的需求不斷增加,也促進了生命徵象監測系統市場的成長。此外,該地區擁有良好的基本醫療設備報銷制度,提高了醫療保健服務的認知度和可近性,從而帶來了高需求。
According to Stratistics MRC, the Global Vital Signs Monitoring Systems Market is accounted for $10.1 billion in 2023 and is expected to reach $20.4 billion by 2030 growing at a CAGR of 10.5% during the forecast period. Vital Signs Monitoring Systems are advanced medical devices designed to track crucial physiological parameters, ensuring timely detection of health abnormalities. These systems continuously monitor indicators such as heart rate, blood pressure, respiratory rate, and body temperature. Utilizing cutting-edge sensor technology, they provide real-time data, enabling healthcare professionals to promptly respond to fluctuations in a patient's condition. Portable and user-friendly, these systems enhance patient care by facilitating remote monitoring and early intervention.
According to the Global Health Observatory data, in 2019, 71% of the deaths were due to Non-Communicable Diseases (NCDs). The major NCDs are Cardiovascular Diseases (CVDs), which caused 45.0% of all NCD deaths, cancer caused 22.0% of all NCD deaths, and Chronic Obstructive Pulmonary Disease (COPD) caused 10.0% of all NCD deaths, and diabetes caused 4.0% of all NCD deaths.
Increasing prevalence of chronic diseases
As conditions like hypertension, diabetes, and cardiovascular diseases become more prevalent, the demand for continuous health monitoring escalates. Vital Signs Monitoring Systems play a pivotal role by providing real-time data on crucial parameters, aiding in early detection and management of chronic conditions. The market experiences a surge in demand for user-friendly, remote monitoring solutions, fostering innovation in technology. With an increasing emphasis on preventive healthcare, the market expands to address the growing needs of patients and healthcare providers, contributing to the dynamic landscape of comprehensive health monitoring systems.
High initial costs and ongoing expenses
Healthcare institutions may hesitate to invest in these systems, especially in resource-limited environments. The financial burden limits widespread adoption, hindering accessibility for both providers and patients. This obstacle slows the integration of advanced monitoring technologies into mainstream healthcare practices, impeding the potential benefits of continuous, remote patient monitoring.
Growing demand for home-based healthcare
Individuals seek more convenient and personalized healthcare solutions, there is an increasing preference for monitoring vital signs at home. Vital Signs Monitoring Systems cater to this demand by offering user-friendly, portable devices that enable continuous health tracking. The market experiences a surge in innovations such as wearable monitoring devices and telehealth integrations, facilitating remote patient care. The shift towards home-based healthcare, accelerated by factors like aging populations and the COVID-19 pandemic, propels the market's expansion, meeting the evolving needs of patients for proactive and accessible health monitoring solutions.
Increasing reliance on digital platforms for data storage
Cybersecurity threats pose a significant risk, potentially compromising sensitive patient information. This raises reluctance among healthcare providers and patients, hindering widespread adoption. Fear of unauthorized access and data breaches may impede the integration of advanced monitoring technologies into mainstream healthcare practices. Thus, addressing and mitigating these security challenges are vital to building trust in digital healthcare solutions, ensuring the safe and ethical use of patient data, and fostering the sustained growth of the market.
Covid-19 Impact
With a heightened focus on remote patient monitoring and telehealth, healthcare providers increasingly utilize these systems to monitor COVID-19 patients remotely. The demand for non-contact vital signs monitoring solutions has surged to minimize virus transmission. Additionally, the pandemic has underscored the importance of early detection and continuous monitoring, driving investments in advanced technologies. The market has witnessed increased innovation and collaboration to meet the evolving healthcare landscape, emphasizing the role of Vital Signs Monitoring Systems in enhancing patient care and supporting healthcare professionals during the ongoing global health crisis.
The blood pressure monitors segment is expected to be the largest during the forecast period
The blood pressure monitors segment is estimated to have a lucrative growth, due to increasing prevalence of hypertension and cardiovascular diseases drives the demand for at-home blood pressure monitoring devices, fostering a parallel rise in comprehensive vital signs monitoring systems. Advanced integration of blood pressure monitoring into these systems enhances their diagnostic capabilities, attracting both healthcare professionals and consumers. Further the market experiences innovation and competitive expansion as technology evolves, offering more accurate and user-friendly solutions.
The ambulatory blood pressure monitors segment is expected to have the highest CAGR during the forecast period
The ambulatory blood pressure monitors segment is anticipated to witness the highest CAGR growth during the forecast period, owing to the demand for continuous and remote patient monitoring, ambulatory blood pressure monitors play a pivotal role in providing real-time data outside clinical settings. Their integration into comprehensive monitoring systems expands the market's scope, enabling a more holistic health assessment. Ambulatory monitors contribute to a dynamic market landscape, addressing the evolving preferences of healthcare professionals and patients for convenient and continuous vital signs tracking, ultimately fostering innovation and competitiveness within the broader monitoring systems market.
Asia Pacific is projected to hold the largest market share during the forecast period owing to the growing geriatric population, rising occurrences of interminable disorders, and developing interest in remote and wireless devices combined with streamlined coverage policies are the main considerations credited to its share. This can be attributed to the extensive unmet needs in this region including primary healthcare, especially in developing markets, such as India and China. Moreover, the rising medical tourism and improving healthcare sectors in this region have a lot to offer the market players over the forecast period.
North America is projected to have the highest CAGR over the forecast period, owing to owing to its high population base, high disposable incomes, improvement in patient awareness about advanced monitoring devices, and increase in incidences of infectious diseases such as malaria and typhoid. Moreover, rise in geriatric population and increase in demand for vital signs monitoring devices for home care settings have contributed to the vital signs monitoring devices market growth. Thus the region also has high awareness and access to healthcare services with strong reimbursement coverage for essential medical devices, thereby leading to high demand.
Key players in the market
Some of the key players in the Vital Signs Monitoring Systems Market include CONTEC Medical Systems Co., Ltd., Criticare Systems, Inc., General Electric Company, Infinium Medical, Masimo Corporation, Medtronic plc, Mindray Medical International Limited, Natus Medical Incorporated, Nihon Kohden Corporation, Nonin Medical, Inc., Omron Healthcare, Philips Healthcare, Progetti srl, Rapid Response Monitoring, Schiller AG, Smiths Medical, Spacelabs Healthcare, SunTech Medical and Welch Allyn
In February 2024, Masimo and UCHealth Announce a Clinical Monitoring Partnership to Improve Care with Telehealth. The collaboration is designed to leverage the unique capabilities of both organizations and pursue their mutual goals of improving patient outcomes, reducing the cost of care, and transforming models of care delivery across the continuum
In January 2024, Medtronic Diabetes announces world's first approval for MiniMed(TM) 780G Systems with Simplera Sync(TM) disposable, all-in-one sensor. The MiniMed 780G system with Simplera Sync(TM) sensor will be available in Europe via limited release in spring 2024.
In January 2024, Mindray Unveils UX Series Endoscope Camera System, Empowering Surgical Precision with Innovative Technology. By integrating a new generation hardware platform with advanced software algorithms, the UX Series sets a new standard for image performance and potential for future expandability.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.